Is my portfolio
One Report to Answer all your Questions!
Alivus Life Sciences Ltd.
BSE: 543322 | NSE: ALIVUS
Small Cap | Pharmaceuticals & Drugs
900.20
10.60 (1.19%) Glenmark Life Sciences informs about earnings call transcript
Date: 27-10-2022Glenmark Life Sciences has informed that the transcript of the Earnings call held on Friday, October 21, 2022 for the quarter and half year ended September 30, 2022 is available on the Company's website at: https://www.glenmarklifesciences.com/pdf/Transcript%20of%20Earnings%20Concall%20Q2%20FY2022-23.pdf The said transcript is also attached.
The above information is a part of company’s filings submitted to BSE.